Prakt. lékáren. 2012; 8(5): 217-224 [Pediatr. praxi. 2012;13(3):167-173]

Prebiotics and probiotics in paediatrics

prof.MUDr.Jiří Nevoral, CSc.
Pediatrická klinika UK 2. LF a FN Motol, Praha

Probiotics have received increased attention in recent years. There are a large number of papers evaluating their effect in various diseases,

but only relatively few studies are of a really high quality. Probiotics act by several mechanisms, such as intestinal pH reduction,

decreased colonization by pathogenic microorganisms, and modulation of immune response. A positive effect of one probiotic in a certain

situation may not necessarily be apparent with the use of another probiotic. Probiotics have been clearly shown to be effective in

treating gastrointestinal diseases, such as acute viral gastroenteritis, antibiotic-associated diarrhoea, traveller‘s diarrhoea, and pouchitis.

Studies have also demonstrated their efficacy in maintaining remission in the treatment of idiopathic proctocolitis and irritable bowel

syndrome. Study findings imply that administration of probiotics significantly reduces the risk of severe necrotizing enterocolitis and,

thus, that of mortality in premature infants. Enrichment of infant milk formulas with probiotics is safe, but data on their long-term positive

effect on the health of children are still lacking. There are certain data indicating that enrichment of infant milk formulas with probiotics

results in lower morbidity rates and a lower incidence of atopic disease in otherwise healthy infants. However, their long-term positive

effect on the developing immune system is yet to be proved. The importance of probiotics in the primary prevention of allergies has

been evaluated, with some studies having shown a positive effect of probiotics on early manifestation of atopic eczema; however, other

similar studies have shown no effect. The study of therapeutic use of probiotics requires randomized, double-blind, placebo-controlled

studies, which is the only way to adequately assess the efficacy and safety of individual probiotics. Current knowledge suggests that

oral administration of probiotics may clearly be of therapeutic benefit in some diseases.

Keywords: probiotics, prebiotics, oligosaccharides, microbiome

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoral J. Prebiotics and probiotics in paediatrics. Praktické lékárenství. 2012;8(5):217-224.
Download citation

References

  1. Westerbeek EA, van der Berg JP, Lafeber HN, et al. Neutral and acidic oligosaccharides in preterm infants: a randomized, double blind placebo controlled trial. Am J Clin Nutr 2010; 91: 679-686. Go to original source... Go to PubMed...
  2. Moro G, Arslanoglu S, Stahl B, et al. A mixture od prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first 6 months of age. Arch Dis Child 2006; 91: 814-819. Go to original source... Go to PubMed...
  3. Arslanoglu S, Moro G, Schmitt J, et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008; 138: 1091-1095. Go to original source... Go to PubMed...
  4. Scholtens PA, Alliet P, Raes M, et al. Fecal secretory immunoglobilin A is increased in healthy infants who receive formula with short-chain galacto-oligoosaccharides and long-chain fructo-oligosaccharides J. Nutr 2008; 138: 1141-1147. Go to original source... Go to PubMed...
  5. Guarino A, Albano F, Ashkenazi S, et al. ESPGHAN/ESOID Evidence based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 2008; 46: 619-621. Go to original source... Go to PubMed...
  6. Szajewska H, Skórka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther 2009; 30: 955-963. Go to original source... Go to PubMed...
  7. Kalliomäki M, Salminen S, Poussa T, et al. Probiotics during the first 7 years of life: a cumulative risk creduction of eczema in as randomized placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021. Go to original source... Go to PubMed...
  8. Deshpande G, Rao S, Patole S, et al. Updated meta-analysis of probiotics for preventing necrozizing enterocolitis in preterm neonates. Pediatrics 2010; 125: 921-930. Go to original source... Go to PubMed...
  9. Sood A, Midha V, Makharia GK, et al. The probiotic preparation VSL#3 induces remission in patients with mild to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009; 7: 1202-1209. Go to original source... Go to PubMed...
  10. Miele E, Pascarella F, Giannetti E, et al. Effect of probiotic preparation on induction and maintenance of remission in children with ulcerative colitis. Am J gastroenterol 2009; 104: 437-443. Go to original source... Go to PubMed...
  11. Kruis W, Frič P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-1623. Go to original source... Go to PubMed...
  12. Viela EG, Ferrari M, Torres HO, et al. Influence of Sacharomyces boulardii on the intesatinal permeability of patients with Crohn´s disease in remission. Scand J gastroenterol Hepatol 2009; 7: 1202-1209.
  13. McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 7,14(17): 2650-2661. Go to original source... Go to PubMed...
  14. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo controlled trial. Pediatrics 2010;126(3): e526-33. Epub 2010 Aug 16. Go to original source... Go to PubMed...
  15. Sýkora J, Valecková K, Amlerová J, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol. 2005; 39(8): 692-698. Go to original source... Go to PubMed...
  16. Hurduc V, Plesca D, Dragomir D, et al. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr 2009; 98: 127-131. Go to original source... Go to PubMed...
  17. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. Br J Nutr 2009; 101(11): 1722-1726. Epub 2008 Nov 6. Go to original source... Go to PubMed...
  18. Kukkonen K, Savilahti E, Haahtela T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122(1): 8-12. Go to original source... Go to PubMed...
  19. Kalliomäki M, Collado MC, Salminen S, et al. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008; 87(3): 534-538. Go to original source... Go to PubMed...
  20. ESPGHAN Committee on Nutrition: Supplementation of infant formula with probiotics and/or prebiotics: A systemic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2011; 52: 238-250. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.